高级检索

2001—2011年辽宁省三级医院适宜急性心肌梗死患者早期接受β受体阻滞剂的治疗趋势

  • 摘要: 目的:评估2001—2011年急性心肌梗死(acute myocardial infarction,AMI)住院患者中适宜使用β受体阻滞剂(β-blocker, βB)的人群在住院早期(入院24 h内)使用βB的情况。方法:随机抽取辽宁省10家协作医院(均为三级医院)2001年、2006年、2011年诊断为AMI的住院患者,提取其临床信息,分析其中无βB禁忌症患者的相关情况,分析上述3年βB的使用率、种类和剂量。结果:入选的1 365例AMI患者中,296例(21.68%)为住院早期βB适宜人群(2001年、2006年、2011年分别为26例、57例、213例)。在适宜人群中βB使用率为2001年53.10%、2006年68.70%、2011年78.00%(P<0.001)。Logistic回归分析显示,心率与早期βB的使用有关。3年中,使用率最高的βB为美托洛尔(90.73%),但其剂量达到指南推荐的50 mg以上者仅为1.46%。结论:2001—2011年辽宁省AMI患者适宜人群中住院早期βB的使用率呈逐年增长的趋势,但使用情况与指南推荐之间存在明显的差距。虽然早期βB应用可减少心血管事件的发生,但患者的心率等影响其应用,因此应遵循循证医学证据结合个体化原则早期应用。

     

    Abstract: Objective:To assess the usage of β-blocker in patients with acute myocardial infarction (AMI) in early hospitalization period (admission within 24 hours) in Liaoning Province from 2001 to 2011. Methods:By convenience sampling, patients from 10 hospitals in 3 study years (2001, 2006, and 2011) were randomly selected and clinical data were extracted, the usage frequency, types and dosage of β-blocker were analyzed. Results:A total of 1 365 AMI patients from ten hospitals were included in this analysis, and about 296 cases (21.68%) were considered as ideal patients for early β-blocker use (53.10% cases in 2001, 68.70% cases in 2006, and 78% cases in 2011, P<0.001). Logistic regression analysis showed that the heart rate was related to the early usage of β-blocker. The most frequently used β-blocker was metoprolol (90.73%) within 3 years, only 1.46% had the dosage above 50 mg. Conclusions:During the past decade, the utilization rate of βB among the appropriate patients with AMI during the earlyphase hospitalization in Liaoning Province present the increasing trend. However, there is a distinct gap between the utilization status and guideline. Although the early application can reduce the occurrence of cardiovascular event, the heart rate of patients and so on are the main causes that influence its application. Therefore, regarding the early application, it is necessary to comply with the evidencebased medical science and combine it with the individualization principle.

     

/

返回文章
返回